The emerging approach of this peptide represents a significant advance in the handling of the condition. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment